Edwards Lifesciences Forecast, price target & analysts
$76.04
1.21%
day before yesterday
NYSE,
Apr 25, 10:10 pm CET
Edwards Lifesciences Target price 2025 - Analyst rating & recommendation
Powered by
Edwards Lifesciences Classifications & Recommendation:
Buy
50%
Hold
47%
Sell
3%
Edwards Lifesciences Price Target
| Target Price | $80.33 |
| Price | $76.04 |
| Potential |
5.64%
register free of charge
|
| Number of Estimates | 27 |
|
27 Analysts have issued a price target Edwards Lifesciences 2026 .
The average Edwards Lifesciences target price is $80.33.
This is
5.64%
register free of charge
$90.00
18.36%
register free of charge
$61.00
19.78%
register free of charge
|
|
| A rating was issued by 32 analysts: 16 Analysts recommend Edwards Lifesciences to buy, 15 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Edwards Lifesciences stock has an average upside potential 2026 of
5.64%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2029
Create a premium account to unlock analyst estimates.
Learn more
Powered by
Quarter
Annually
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion $ | 5.44 | 5.90 |
| 8.57% | 8.55% | |
| EBITDA Margin | 29.41% | 29.91% |
| 6.30% | 1.72% |
29 Analysts have issued a sales forecast Edwards Lifesciences 2025 . The average Edwards Lifesciences sales estimate is
$5.9b
Unlock
6.60%
higher
Unlock
$6.0b
8.83%
Unlock
$5.8b
5.46%
Unlock
This results in the following potential growth metrics:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029
Create a premium account to unlock analyst estimates.
Learn more
Powered by
Quarter
Annually
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 1.46 | 2.45 |
| 36.52% | 67.81% | |
| P/E | 31.02 | |
| EV/Sales | 7.12 |
16 Analysts have issued a Edwards Lifesciences forecast for earnings per share. The average Edwards Lifesciences EPS is
$2.45
Unlock
1.21%
lower
Unlock
$2.70
8.87%
Unlock
$2.32
6.45%
Unlock
This results in the following potential growth metrics and future valuations:
Edwards Lifesciences...
Current Edwards Lifesciences Upgrades & Downgrades
Create a Premium account to unlock Upgrades/Downgrades.
Learn more
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Canaccord Genuity |
Locked
➜
Locked
|
Locked | Apr 25 2025 |
| Piper Sandler |
Locked
➜
Locked
|
Locked | Apr 24 2025 |
| Baird |
Locked
➜
Locked
|
Locked | Apr 24 2025 |
| Truist Securities |
Locked
➜
Locked
|
Locked | Apr 11 2025 |
| Barclays |
Locked
➜
Locked
|
Locked | Feb 13 2025 |
| Canaccord Genuity |
Locked
➜
Locked
|
Locked | Feb 13 2025 |
| Evercore ISI Group |
Locked
➜
Locked
|
Locked | Feb 12 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
Apr 25 2025 |
|
Locked
Piper Sandler:
Locked
➜
Locked
|
Apr 24 2025 |
|
Locked
Baird:
Locked
➜
Locked
|
Apr 24 2025 |
|
Locked
Truist Securities:
Locked
➜
Locked
|
Apr 11 2025 |
|
Locked
Barclays:
Locked
➜
Locked
|
Feb 13 2025 |
|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
Feb 13 2025 |
|
Locked
Evercore ISI Group:
Locked
➜
Locked
|
Feb 12 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
